Literature DB >> 34711455

Neurocognition and Health-Related Quality of Life Among Patients with Brain Tumors.

Kyle Noll1, Amanda L King2, Linda Dirven3, Terri S Armstrong4, Martin J B Taphoorn3, Jeffrey S Wefel5.   

Abstract

Patients with brain tumors experience great symptom burden across various domains of functioning, with associated decreases in health-related quality of life and general well-being. Impaired neurocognitive functioning is among the primary concerns of these patients. Unfortunately, most patients will experience such impairment at some point in the disease. However, impaired neurocognitive functioning, symptom burden, and well-being vary according numerous patient-, tumor-, and treatment-related factors. Recent work has furthered our understanding of these contributors to patient functioning and health-related quality of life and also points to various potential targets for prevention and intervention strategies, though more efficacious treatments remain needed.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain tumor; Neuro-oncology; Neurocognitive function; Neuropsychology; Quality of life

Mesh:

Year:  2021        PMID: 34711455     DOI: 10.1016/j.hoc.2021.08.011

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  1 in total

1.  The Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessments.

Authors:  Varna Jammula; James L Rogers; Elizabeth Vera; Alexa Christ; Heather E Leeper; Alvina Acquaye; Nicole Briceno; Anna Choi; Ewa Grajkowska; Jason E Levine; Matthew Lindsley; Jennifer Reyes; Kayla N Roche; Michael Timmer; Lisa Boris; Eric Burton; Nicole Lollo; Marissa Panzer; Matthew A Smith-Cohn; Marta Penas-Prado; Valentina Pillai; Brett J Theeler; Jing Wu; Mark R Gilbert; Terri S Armstrong
Journal:  Neurooncol Pract       Date:  2022-05-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.